Clinical Efficacy of 125I Brachytherapy Combined With Anlotinib in Radioiodine Refractory Thyroid Carcinoma Patients

Clinical trial NCT06367010 · COMPLETED

Trial details

NCT number: NCT06367010
Sponsor: Jiangxi Provincial Cancer Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Thyroid Neoplasms

Start date: 2019-01-01
Primary completion: 2024-04-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.